Optum’s biosimilar business to exclude brand-name Stelara, Humira in 2025

Op­tum Rx is mov­ing in­to the biosim­i­lar busi­ness with a com­pa­ny it’s call­ing Nu­vaila, and it’s start­ing out with biosim­i­lars to Ab­b­Vie’s block­buster rheuma­toid arthri­tis …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

A Big Round Trip

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

Read More »